Abstract:Abstract Epilepsies of early childhood are frequently resistant to therapy and often associated with cognitive and behavioural comorbidity. Aetiology focused precision medicine, notably gene-based therapies, may prevent seizures and comorbidities. Epidemiological data utilizing modern diagnostic techniques including whole genome sequencing and neuroimaging can inform diagnostic strategies and therapeutic trials. We present a 3-year, multicentre prospective cohort study, involving all children under 3 years of age in Scotland presenting with epilepsies. We used two independent sources for case identification: clinical reporting and EEG record review. Capture-recapture methodology was then used to improve the accuracy of incidence estimates. Socio-demographic and clinical details were obtained at presentation, and 24 months later. Children were extensively investigated for aetiology. Whole genome sequencing was offered for all patients with drug-resistant epilepsy for whom no aetiology could yet be identified. Multivariate logistic regression modelling was used to determine associations between clinical features, aetiology, and outcome. Three hundred and ninety children were recruited over 3 years. The adjusted incidence of epilepsies presenting in the first 3 years of life was 239 per 100 000 live births [95% confidence interval (CI) 216–263]. There was a socio-economic gradient to incidence, with a significantly higher incidence in the most deprived quintile (301 per 100 000 live births, 95% CI 251–357) compared with the least deprived quintile (182 per 100 000 live births, 95% CI 139–233), χ2 odds ratio = 1.7 (95% CI 1.3–2.2). The relationship between deprivation and incidence was only observed in the group without identified aetiology, suggesting that populations living in higher deprivation areas have greater multifactorial risk for epilepsy. Aetiology was determined in 54% of children, and epilepsy syndrome was classified in 54%. Thirty-one per cent had an identified genetic cause for their epilepsy. We present novel data on the aetiological spectrum of the most commonly presenting epilepsies of early childhood. Twenty-four months after presentation, 36% of children had drug-resistant epilepsy (DRE), and 49% had global developmental delay (GDD). Identification of an aetiology was the strongest determinant of both DRE and GDD. Aetiology was determined in 82% of those with DRE, and 75% of those with GDD. In young children with epilepsy, genetic testing should be prioritized as it has the highest yield of any investigation and is most likely to inform precision therapy and prognosis. Epilepsies in early childhood are 30% more common than previously reported. Epilepsies of undetermined aetiology present more frequently in deprived communities. This likely reflects increased multifactorial risk within these populations.

Development and validation of an epidemiologic case definition of epilepsy for use with routinely collected Australian health data

The accuracy of using administrative healthcare data to identify epilepsy cases: A systematic review of validation studies

Validating the accuracy of administrative healthcare data identifying epilepsy in deceased adults: A Scottish data linkage study

EPI-VALID : Validation of an algorithm for identifying patients with epilepsy in the SNDS using data from the CONSTANCES cohort

Estimating the likelihood of epilepsy from clinically noncontributory electroencephalograms using computational analysis: A retrospective, multisite case–control study

Case-control study developing Scottish Epilepsy Deaths Study score to predict epilepsy-related death

A sustainable artificial-intelligence-augmented digital care pathway for epilepsy: Automating seizure tracking based on electroencephalogram data using artificial intelligence

Identification of drug resistance in a validated cohort of incident epilepsy patients in the Danish National Patient Register

An algorithm for drug-resistant epilepsy in Danish national registers

Development and validation of a predictive model for the diagnosis of neural antibody-mediated epilepsy/ seizure in patients with new-onset seizure or established epilepsy

Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants

Improving epilepsy diagnosis across the lifespan: approaches and innovations

Testing the diagnostic accuracy of common questions for seizure diagnosis: Challenges and future directions

Diagnostic utility of prolonged ambulatory video-electroencephalography monitoring

Incidence and Prevalence of Childhood Epilepsy: A Nationwide Cohort Study

Decision Support System for Classification of Epilepsies in Childhood

ILAE Official Report: A practical clinical definition of epilepsy

Efficient diagnosis leads to better care: streamlining epilepsy diagnosis pathways

Advancing epilepsy diagnosis: A meta-analysis of artificial intelligence approaches for interictal epileptiform discharge detection

Early Identification of Candidates for Epilepsy Surgery